Investigating traditional Chinese medicine for vascular dementia treatment
SINGAPORE: Vascular dementia is the second most common cause of dementia, and there’s no good… read more
MGC gets green light for cannabis dementia drug trial
PERTH: ASX listed biotech MGC Pharmaceuticals has secured a key approval from Australia’s Therapeutic Goods… read more
Even low-level activity may help reduce dementia risk
CHICAGO: Recent research suggests that doing even low-intensity physical activity allows older people to reduce… read more
